title: Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.
authors.affiliation: BIO Ventures for Global Health, San Francisco, California, United States of America. rstefanakis@bvgh.org
authors.forename: Rianna
authors.initials: R
authors.lastname: Stefanakis
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Robertson
authors.forename: Elizabeth L
authors.initials: EL
authors.lastname: Ponder
authors.forename: Melinda
authors.initials: M
authors.lastname: Moree
mesh_terms: D003141:Communicable Diseases / Q000188:drug therapy* / Q000453:epidemiology; D017277:Drug Approval; D055808:Drug Discovery / Q000639:trends*; D006801:Humans; D058069:Neglected Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D014330:Tropical Medicine / Q000639:trends; D014481:United States; D014486:United States Food and Drug Administration; D014612:Vaccines / Q000276:immunology*
chemical_list: D014612:Vaccines